Science and Research

Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency

BACKGROUND: The recognition of viral nucleic acids is one of the primary triggers for a type I interferon-mediated antiviral immune response. Inborn errors of type I interferon immunity can be associated with increased inflammation and/or increased susceptibility to viral infections, as a result of dysbalanced interferon production. NFX1-type zinc-finger-containing 1 (ZNFX1) is an interferon-stimulated double-strand RNA sensor that restricts the replication of RNA viruses in mice. ZNFX1's role in the human immune response is not known. OBJECTIVE: We studied 15 patients from 8 families with an autosomal recessive immunodeficiency characterized by severe infections by both RNA and DNA viruses and virally triggered inflammatory episodes with hemophagocytic-lymphohistiocytosis-like disease, early-onset seizures, as well as renal and lung disease. METHODS: Whole exome sequencing was performed on 13 patients from 8 families. We investigated the transcriptome, post-transcriptional regulation of interferon-stimulated genes (ISGs) and predisposition to viral infections in primary cells from patients and controls stimulated with synthetic double-stranded nucleic acids. RESULTS: Deleterious homozygous and compound heterozygous ZNFX1 variants were identified in all 13 patients. Stimulation of patient-derived primary cells with synthetic double-stranded nucleic acids was associated with a deregulated pattern of expression of ISGs and alterations in the half-life of ISGs mRNA and was associated with poorer clearance of virus infections by monocytes. CONCLUSION: ZNFX1 is an important regulator of the response to double-stranded nucleic acids stimuli following viral infections. ZNFX1 deficiency predisposes to severe viral infections and a multisystem inflammatory disease.

  • Vavassori, S.
  • Chou, J.
  • Faletti, L. E.
  • Haunerdinger, V.
  • Opitz, L.
  • Joset, P.
  • Fraser, C. J.
  • Prader, S.
  • Gao, X.
  • Schuch, L. A.
  • Wagner, M.
  • Hoefele, J.
  • Maccari, M. E.
  • Zhu, Y.
  • Elakis, G.
  • Gabbett, M. T.
  • Forstner, M.
  • Omran, H.
  • Kaiser, T.
  • Kessler, C.
  • Olbrich, H.
  • Frosk, P.
  • Almutairi, A.
  • Platt, C. D.
  • Elkins, M.
  • Weeks, S.
  • Rubin, T.
  • Planas, R.
  • Marchetti, T.
  • Koovely, D.
  • Klämbt, V.
  • Soliman, N. A.
  • von Hardenberg, S.
  • Klemann, C.
  • Baumann, U.
  • Lenz, D.
  • Klein-Franke, A.
  • Schwemmle, M.
  • Huber, M.
  • Sturm, E.
  • Hartleif, S.
  • Häffner, K.
  • Gimpel, C.
  • Brotschi, B.
  • Laube, G.
  • Güngör, T.
  • Buckley, M. F.
  • Kottke, R.
  • Staufner, C.
  • Hildebrandt, F.
  • Reu-Hofer, S.
  • Moll, S.
  • Weber, A.
  • Kaur, H.
  • Ehl, S.
  • Hiller, S.
  • Geha, R.
  • Roscioli, T.
  • Griese, M.
  • Schmid, J. P.

Keywords

  • HLH-like disease
  • Znfx1
  • brain calcification
  • interstitial lung disease
  • leukoencephalopathy
  • susceptibility to viral infections
  • thrombotic microangiopathy
  • type I interferon
  • virally induced hepatitis
Publication details
DOI: 10.1016/j.jaci.2021.03.045
Journal: J Allergy Clin Immunol
Work Type: Original
Location: CPC-M
Disease Area: AA
Partner / Member: KUM
Access-Number: 33872655

DZL Engagements

chevron-down